SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-090828
Filing Date
2024-08-05
Accepted
2024-08-05 16:30:58
Documents
88
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q axsm-20240630.htm   iXBRL 10-Q 2382632
2 EX-31.1 axsm-ex31_1.htm EX-31.1 14833
3 EX-31.2 axsm-ex31_2.htm EX-31.2 14735
4 EX-32.1 axsm-ex32_1.htm EX-32.1 6823
5 EX-32.2 axsm-ex32_2.htm EX-32.2 6801
  Complete submission text file 0000950170-24-090828.txt   10236948

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT axsm-20240630.xsd EX-101.SCH 1525274
91 EXTRACTED XBRL INSTANCE DOCUMENT axsm-20240630_htm.xml XML 1737656
Mailing Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007
Business Address ONE WORLD TRADE CENTER, 22ND FLOOR NEW YORK NY 10007 (212) 332-3241
Axsome Therapeutics, Inc. (Filer) CIK: 0001579428 (see all company filings)

IRS No.: 454241907 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37635 | Film No.: 241175263
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)